Inventor
Christopher M. Clemens
Inventor
Madison, WI, US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
C07KPeptides22%
Y02ATechnologies for adaptation to climate change22%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
PatentTitleYear
6,693,083'Conjugates targeted to the interleukin-2 receptor'20046,656,468'Clostridial toxin disease therapy'20036,251,866'Conjugates targeted to the interleukin-2 receptor'20015,814,477'Recombinant clostridial toxin protein'19985,762,934'Clostridium difficile toxin disease therapy'19985,719,267'Clostridial toxin disease therapy'19985,601,823'Avian antitoxins to clostridium difficle toxin A'19975,599,539'Therapy for clostridial botulinum toxin'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–1998Patents assigned to OPHIDIAN PHARM INC (5)· patent assignee history
1997–2003Based in Madison, WI, US· patent location history
2001Patents assigned to WATSON LAB INC (1)· patent assignee history
2001–2004Based in Salt Lake City, UT, US· patent location history
2003Patents assigned to PROMEGA CORP (1)· patent assignee history
2004Patents assigned to WATSON PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OPHIDIAN PHARM INC | 5 | 1997–1998 |
| PROMEGA CORP | 1 | 2003 |
| WATSON LAB INC | 1 | 2001 |
| WATSON PHARMACEUTICALS INC | 1 | 2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| Madison, WI, US | 6 | 1997–2003 |
| Salt Lake City, UT, US | 2 | 2001–2004 |